Concepedia

Yuishin Izumi

YI

Statistics

Publications

7

Citations

655

H-Index

7

Active since

2017

Affiliations

Tokushima University(Current)

Kyoto University

RIKEN BioResource Research Center

University of Tsukuba

Fukushima Medical University

Yuishin Izumi is an author at Tokushima University specializing in neurodegenerative diseases, neurodegenerative disorders, and neuroscience.

ORCID

Publications per year

2017–2022

7

Publications

7

The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis

Keiko Imamura, Yuishin Izumi, Akira Watanabe et al. · Science Translational Medicine · 2017 · 256 citations · Full text

, , +13

iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease

Takayuki Kondo, Keiko Imamura, Misato Funayama et al. · Cell Reports · 2017 · 232 citations · Full text

, , +17

Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells

Keiko Imamura, Yuichiro Yada, Yuishin Izumi et al. · Annals of Neurology · 2021 · 51 citations · Full text

, , +17

Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs

Kosuke Matsuzono, Keiko Imamura, Nagahisa Murakami et al. · Molecular Therapy — Nucleic Acids · 2017 · 43 citations · Full text

, , +15

Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations

Takayuki Kondo, Haruhiko Banno, Taro Okunomiya et al. · BMJ Open · 2021 · 27 citations · Full text

, , +17

1–5 of 7